RESEARCH TRIANGLE PARK, N.C., March 15, 2017 /PRNewswire/ -- Mr. Patel joins Kymanox as an accomplished Operations Director with more than 20 years
Mr. Patel earned a degree in Electrical Engineering from the University of Sunderland in England, and is a Master of Business Administration (MBA) from Copenhagen Business School in Denmark. He maintains professional certifications in Quality Auditing (ASQ-CQA), Supply Chain (CSCP), and Quality Management / Organizational Excellence (ASQ-CMQ/OE).
Mr. Patel states, "I am very excited to be part of this family. The offerings we provide to Biotech, Pharmaceutical, Medical Device, and Sterile Pharmacy organizations is expansive and inclusive of many disciplines. We are providing world-class service unmatched in quality and net value. I look forward to building on the strong foundations and relationships already here."
"Ash is a strategic addition to the Kymanox team," CEO and Founder Stephen M. Perry remarked. "His new role ensures our continuing ability to understand the complex problems facing our clients who are bringing modern medicines to patients in need around the world."
Established in 2004, Kymanox provides technical and compliance solutions for regulated medicine manufacturing. Clients with important commercialization initiatives are served globally in the Life Science areas of Biotechnology, Pharmaceuticals, and Medical Devices. Leveraging its experienced team and intellectual assets, a broad range of technical services and products are supplied with turnkey project delivery. The Kymanox mission is to improve the human condition by helping make modern medicine manufacturing better, faster, and more affordable.
Kymanox also owns and maintains the following: CMOLocator.com, KymanoxWORKS.com, GMPPENS.com, and KymaPRO.com. Visit http://kymanox.com to learn more.
The company headquarters are in the Research Triangle Park (RTP) in Durham, North Carolina with multiple branch offices in the USA.
Media Contact Laura Penn (Text/Mobile: +1 919-536-9821, Email: firstname.lastname@example.org)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kymanox-growth-continues-signs-former-biogen-director-300424107.html
Subscribe to our Free Newsletters!
Parotidectomy is a surgery to remove a part of or the entire parotid salivary gland, on the side of ...
Brugada syndrome is a rare genetic heart condition that affects the way electrical signals pass ...
Modified Atkins diet designed for weight loss and to treat seizures is high in fat and low in ...View All